RESULTS - The Salt Lake Tribune http://www.sltrib.com/feeds/topics/RESULTS News from The Salt Lake Tribune en-us webmaster@sltrib.com (Webmaster) U.S. stocks climb as earnings reports roll in http://www.sltrib.com/sltrib/money/58210405-79/percent-earnings-prices-results.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58210405-79/percent-earnings-prices-results.html.csp">U.S. stocks climb as earnings reports roll in</a></h4> <span class="author vcard"><span class="fn">By matthew craft</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-22T12:34:42.55-06:00">Updated Jul 22, 2014 12:34PM MDT</span></h5> <div class ="entry-content">NEW YORK • Solid earnings for a range of big companies helped nudge the stock market higher on Tuesday. The restaurant chain Chipotle and the cable giant Comcast surged after reporting better results than Wall Street expected. KEEPING SCORE: The Standard & Poor’s 500 index added 11 points, or 0.6 percent, to 1,984 as of 1:40 p.m. Eastern time. That’s a point from the index’s all-time high closing high on July 3. The Dow Jones industrial average rose 68 points, or 0.4 percent, to 17,119. The Nasd...</div> <h5><a rel="item-license" href="#license-582104052014-07-22T12:34:42.55-06:00" id="#license-2014-07-22T12:34:42.55-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58210405@www.sltrib.com Tue, 22 Jul 2014 12:34:42 MDT U.S. stocks mount rebound on company earnings http://www.sltrib.com/sltrib/money/58197872-79/percent-earnings-investors-market.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58197872-79/percent-earnings-investors-market.html.csp">U.S. stocks mount rebound on company earnings</a></h4> <span class="author vcard"><span class="fn">By ALEX VEIGA</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-18T17:07:25.3-06:00">Updated Jul 18, 2014 05:07PM MDT</span></h5> <div class ="entry-content">Investors jumped on a wave of strong corporate financial results Friday, propelling stocks higher for the third time in five days. The gains wiped out much of the market’s losses from the day before, when the downing of a Malaysian Airlines passenger jet in eastern Ukraine stirred concerns that tensions between Russia and the West could escalate. Israel’s launch of a ground offensive into Gaza also stoked geopolitical uncertainty. Those worries appeared to ease Friday, as world leaders called fo...</div> <h5><a rel="item-license" href="#license-581978722014-07-18T17:07:25.3-06:00" id="#license-2014-07-18T17:07:25.3-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58197872@www.sltrib.com Fri, 18 Jul 2014 17:07:25 MDT Company changes name after Hawaiian protests http://www.sltrib.com/sltrib/money/58192055-79/company-hawaiian-bastani-hula.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58192055-79/company-hawaiian-bastani-hula.html.csp">Company changes name after Hawaiian protests</a></h4> <span class="author vcard"><span class="fn">By JENNIFER SINCO KELLEHER</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-16T18:38:02.144-06:00">Updated Jul 16, 2014 06:38PM MDT</span></h5> <div class ="entry-content">Honolulu • A company aiming to provide easier access to sexually transmitted disease test results and other medical records took a new name Wednesday after facing protests by Native Hawaiians for using the word hula. The Los Angeles-based company will now be called Healthvana Inc., founder and CEO Ramin Bastani said. The previous name Hula drew complaints that it was culturally insensitive. An online petition asking Bastani to change the name argued it exploited a sacred cultural dance. Bastani ...</div> <h5><a rel="item-license" href="#license-581920552014-07-16T18:38:02.144-06:00" id="#license-2014-07-16T18:38:02.144-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58192055@www.sltrib.com Wed, 16 Jul 2014 18:38:02 MDT Studies see new risks for cholesterol drug niacin http://www.sltrib.com/sltrib/money/58191985-79/niacin-drug-cholesterol-studies.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58191985-79/niacin-drug-cholesterol-studies.html.csp">Studies see new risks for cholesterol drug niacin</a></h4> <span class="author vcard"><span class="fn">By MARILYNN MARCHIONE</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-16T18:05:02.318-06:00">Updated Jul 16, 2014 06:05PM MDT</span></h5> <div class ="entry-content">New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use. Niacin is a type of B vitamin long sold over the counter and in higher prescription doses. Some people take it alone or with statin medicines such as Lipitor for cholesterol problems. Niacin users’ main complaint has been flushing, so drug companies have be...</div> <h5><a rel="item-license" href="#license-581919852014-07-16T18:05:02.318-06:00" id="#license-2014-07-16T18:05:02.318-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58191985@www.sltrib.com Wed, 16 Jul 2014 18:05:02 MDT Genentech Alzheimer’s drug misses goals in studies http://www.sltrib.com/sltrib/world/58190254-68/drug-alzheimer-genentech-studies.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58190254-68/drug-alzheimer-genentech-studies.html.csp">Genentech Alzheimer’s drug misses goals in studies</a></h4> <span class="author vcard"><span class="fn">By MARILYNN MARCHIONE</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-16T09:59:10.966-06:00">Updated Jul 16, 2014 09:59AM MDT</span></h5> <div class ="entry-content">An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer’s disease, but showed some promise in the least-impaired participants who received a higher dose. Pneumonia and deaths were more common among those receiving the drug, but researchers downplayed that. Study leader Dr. Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rat...</div> <h5><a rel="item-license" href="#license-581902542014-07-16T09:59:10.966-06:00" id="#license-2014-07-16T09:59:10.966-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58190254@www.sltrib.com Wed, 16 Jul 2014 09:59:10 MDT Genentech Alzheimer’s drug misses goals in studies http://www.sltrib.com/sltrib/money/58190049-79/drug-alzheimer-genentech-studies.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58190049-79/drug-alzheimer-genentech-studies.html.csp">Genentech Alzheimer’s drug misses goals in studies</a></h4> <span class="author vcard"><span class="fn">By MARILYNN MARCHIONE</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-16T17:26:12.193-06:00">Updated Jul 16, 2014 05:26PM MDT</span></h5> <div class ="entry-content">An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer’s disease, but showed some promise in the least-impaired participants who received a higher dose. Pneumonia and deaths were more common among those receiving the drug, but researchers downplayed that. Study leader Dr. Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rat...</div> <h5><a rel="item-license" href="#license-581900492014-07-16T17:26:12.193-06:00" id="#license-2014-07-16T17:26:12.193-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58190049@www.sltrib.com Wed, 16 Jul 2014 17:26:12 MDT Goldman Sachs posts higher profit and revenue http://www.sltrib.com/sltrib/money/58186238-79/goldman-percent-revenue-billion.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58186238-79/goldman-percent-revenue-billion.html.csp">Goldman Sachs posts higher profit and revenue</a></h4> <span class="author source-org vcard"><span class="org fn">The Associated Press</span></span> <h5><span class="updated" title="2014-07-15T09:20:01.398-06:00">Updated Jul 15, 2014 09:20AM MDT</span></h5> <div class ="entry-content">New York • Goldman Sachs said Tuesday that its quarterly profit rose 5 percent, helped by record results from investment banking. Second-quarter net income climbed to $1.95 billion from $1.86 billion a year earlier, the bank said early Tuesday. That’s after paying dividends on preferred stock. Analysts had forecast that weak trading revenue would hamper results for Wall Street banks in the second quarter. Goldman’s revenue and earnings were expected to shrink. But the bank said revenue rose 6 pe...</div> <h5><a rel="item-license" href="#license-581862382014-07-15T09:20:01.398-06:00" id="#license-2014-07-15T09:20:01.398-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58186238@www.sltrib.com Tue, 15 Jul 2014 09:20:01 MDT World stocks stumble as gains are reassessed http://www.sltrib.com/sltrib/money/58165217-79/markets-percent-alcoa-europe.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58165217-79/markets-percent-alcoa-europe.html.csp">World stocks stumble as gains are reassessed</a></h4> <span class="author vcard"><span class="fn">By YURI KAGEYAMA</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-09T09:28:51.127-06:00">Updated Jul 9, 2014 09:28AM MDT</span></h5> <div class ="entry-content">Stock markets in Europe steadied Wednesday as Wall Street opened solidly following positive earnings news from aluminum company Alcoa. The company reported better than expected results in an after-hours statement Tuesday. Alcoa traditionally kicks off the quarterly reporting season and its results helped soothe some concerns in the markets. U.S. corporate earnings could be the biggest driver in markets over the coming weeks as investors look for signs that the strengthening U.S. economy has tran...</div> <h5><a rel="item-license" href="#license-581652172014-07-09T09:28:51.127-06:00" id="#license-2014-07-09T09:28:51.127-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58165217@www.sltrib.com Wed, 09 Jul 2014 09:28:51 MDT Alcoa reports quarterly profit but flat revenues http://www.sltrib.com/sltrib/money/58162497-79/alcoa-aluminum-cents-per.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58162497-79/alcoa-aluminum-cents-per.html.csp">Alcoa reports quarterly profit but flat revenues</a></h4> <span class="author source-org vcard"><span class="org fn">The Associated Press</span></span> <h5><span class="updated" title="2014-07-08T16:45:02.566-06:00">Updated Jul 8, 2014 04:45PM MDT</span></h5> <div class ="entry-content">New York • Alcoa Inc. reported a second-quarter profit Tuesday of $138 million, reversing a year-ago loss, and the results beat analysts’ expectations. The company reported strong results in its engineered-products business, which makes parts for industrial customers, while looking to cut costs in its aluminum-smelting segment. Alcoa has struggled in recent years with low aluminum prices and has increased its focus on making sheets and other products for manufacturers of airplanes and autos, who...</div> <h5><a rel="item-license" href="#license-581624972014-07-08T16:45:02.566-06:00" id="#license-2014-07-08T16:45:02.566-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58162497@www.sltrib.com Tue, 08 Jul 2014 16:45:02 MDT Afghan officials: Ahmadzai leads in disputed vote http://www.sltrib.com/sltrib/world/58156706-68/results-election-fraud-officials.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/world/58156706-68/results-election-fraud-officials.html.csp">Afghan officials: Ahmadzai leads in disputed vote</a></h4> <span class="author vcard"><span class="fn">By AMIR SHAH and RAHIM FAIEZ</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-07-07T09:31:17.388-06:00">Updated Jul 7, 2014 09:31AM MDT</span></h5> <div class ="entry-content">Kabul, Afghanistan • Former finance minister Ashraf Ghani Ahmadzai has the lead in Afghanistan’s disputed presidential election, according to a preliminary tally released Monday despite allegations of massive fraud. The announcement came as Ahmadzai is locked in a standoff with his rival Abdullah Abdullah, who has refused to accept any results until all fraudulent ballots are invalidated. The Independent Election Commission acknowledged that vote rigging had occurred and promised to launch a mor...</div> <h5><a rel="item-license" href="#license-581567062014-07-07T09:31:17.388-06:00" id="#license-2014-07-07T09:31:17.388-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58156706@www.sltrib.com Mon, 07 Jul 2014 09:31:17 MDT Bloomberg View: Afghanistan needs its own Al Gore http://www.sltrib.com/sltrib/opinion/58147029-82/results-afghanistan-voting-abdullah.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/opinion/58147029-82/results-afghanistan-voting-abdullah.html.csp">Bloomberg View: Afghanistan needs its own Al Gore</a></h4>